Exicure Inc (XCUR) Quote

WELL? will XCUR become a company that deals with super large 3D advertising digital screens? (you will not need 3D glasses with this technology) or how about becoming a USA distribution hub either involving manufacturing or even if the hub might be just for marketing South Korea's 3D products? Something needs to give way soon.

Like I said XCUR isn't Exicure anymore and with us not actually doing any real development plus of course these guys haven't a clue, at the value of those patents. The players/institutional investments will be playing in Bluejay however you might hope that Bluejay might reverse merger but believe that won't happen.

One reason we won't see what we want in share price is because Exicure isn't Exicure any more. Sure our past management screwed us but these new kids on the block, from Korea had no clue about doing anything within the develop anything meaning their interest (seemed) to be more on having a public trading entity. Proof of the pudding is that they had no idea about the contract development between Exicure and NWU.

We lost massively in all out institutional investments and now are struggling to stay in the NASDAQ household in-which in several more months we most likely will kiss the OTC.

We are just a company trying to give out our valuable patents but just read the latest press release they haven't a clue of the value nor the work that went into all this in past years. So all we will get is crumbs. Now even the company we just made the tiny deal with will be at least 2 - 3 years in developing the studies, mixes and potential pre clinical.

In other words for us who stay for then RS may not but hop and poke with time. As for the traders timing might be bad.

Now the S Korean big dog - money man is successful but I'm not sure about the guy's presently holding offices. Is it possible the company will be more of a business hub between the US and SK?

XCUR: Suddenly appearing upon, and movin' UP, this list --- out of nowhere!!
https://www.barchart.com/investing-ideas/penny-stocks?orderBy=percentChange5d&orderDir=desc

XCUR: Suddenly appearing upon, and movin' UP, this list --- out of nowhere!!
https://www.barchart.com/investing-ideas/penny-stocks?orderBy=percentChange5d&orderDir=desc

XCUR: Here we Gooooooooooo!!! (Maybe there IS a God!!!!) Don't like my Atheistic jokes, then SCREW-YAH!!! Face MECCA, or put your hands on your "WAILING BUTTS"!!!)

If it breaks .80 again...it may grow legs...under 9 million OS?

Thanks the robots gapped it up too high too quick, so didnt have a big trading range

whats your thoughts on the action and the XCUR news

The system can design drug plan(s) digitally and pursue 3 different tasks at the same time, also turning on and off cells and delivering by way of scavenger receptors, delivering less drug, raising efficiency and causing less damage to the liver/patients.

No doubt we needed something but weak statements that lack real information...it appears this effort might be to hold/move share price that may very well work against the company. Being invested in Exicure for around 4 years it appears the other company was in great need of a new way/delivery system plus the 3D digital system which was why I invested in XCUR years ago.

Is it worth buying now?...or wait?

Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis
CHICAGO--(BUSINESS WIRE)-- Exicure, Inc., (NASDAQ:XCUR) a company that historically developed nucleic acid therapies, and Bluejay Therapeutics, Inc., a private clinical stage biopharmaceutical company focused on viral and liver diseases, announced today that Bluejay Therapeutics, Inc. ("Bluejay") and Exicure, Inc. ("Exicure") entered into a patent license agreement to develop cavrotolimod for potential treatment for hepatitis.

Under the terms of the agreement, Bluejay will receive an exclusive license in the field of hepatitis to all of Exicure’s relevant patents. Bluejay paid Exicure an initial small, one-time payment after the execution of this Agreement. Exicure will also be entitled to modest royalties on future net sales on all licensed technology by Bluejay during the term of the licensed patents. Exicure will be responsible for, and make all decisions concerning, the preparation, filing, prosecution, and maintenance for each patent and patent application included within the licensed patents.

"Our partnership with Bluejay continues the development of cavrotolimod," said Paul Kang, Chief Executive Officer of Exicure. "Exicure has spent considerable resources to discover and develop cavrotolimod. While historically, we focused on oncology, Bluejay’s commitment and expertise in developing cavrotolimod for potential treatment of hepatitis makes them an ideal partner to expand the use case of cavrotolimod," added Mr. Kang.

About Exicure

Exicure, Inc. has historically been an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. Following its recent restructuring and suspension of clinical and development activities, the Company is exploring strategic alternatives to maximize stockholder value, both with respect to its historical biotechnology assets and more broadly. For further information, see www.exicuretx.com.

Forward-Looking Statements

XCUR: News launched exactly ONE MINUTE after the Close!! (HAH!!! Is this a 'SYSTEM' of some sort??? To EXPLOIT the Post-M??? Inquiring minds need to know!!!)


When we got married!!!


On our Honeymoon!!!

Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the Treatment of Hepatitis

Paul Kang will reverse a private company into XCUR but in the meantime he has paid directors the typical $20k so that he can maintain listing and also push the the SEC tolerances to the limit before actually being delisted. I believe we will not be involved in any of the past operations that we were and I believe from all the reading I have done. I keep shaking my head on what business we will do and feel that Mr. Kang is using Exicure as a shell company. I had hope that we would become some type of business hub focused on renewable energy I mean 30k sq ft isn't bad for starters plus half of that is leased office staff is already and believe it to be a S. Korean entity.

Subslover....we are at 55 days of 60 for management to send a plan to the SEC to enable XCUR to remain on the Nasdaq.

XCUR........................................https://stockcharts.com/h-sc/ui?s=XCUR&p=W&b=5&g=0&id=p86431144783

Short manipulators out in force premarket trying to keep their azzas from getting squeezed over a buck, like they were getting in thevafter hours,

Exicure Granted Broad U.S. Patent #11866700 Today For "Liposomal Nucleic Acid Constructs Presenting Antisense Oligonucleotides For Knockdown Of Interleukin 17 Mrna (For Inflammation From Cancer, Obesity, Diabetes, Alzheimer's)"

XCUR $1.00?

XCUR.............................https://stockcharts.com/h-sc/ui?s=XCUR&p=W&b=5&g=0&id=p86431144783

We might have a market maker buying up all these shares we have seen in the past week or so. I mean you know XCUR is in a real bind about getting delisted to the OTC and the business hope is clear they need a private company to reverse merge but what will we become. Northwestern University is done with us as I see things. Seems Exicure has leased half of their corporate floor area so what is next? I still sense something referencing South Korea...maybe importing exporting???

PURE GARBAGE !! DUMPOOOOOOO

It seems someone is taking up house keeping in Exicure.

Since we did not hear anything from Exicure yet I would think someone loaned the company money however, if we do have a business deal that might be announced after close tonight I have no doubt we will head in a entirely different direction if that is the case. Is there a private company wishing to go public, that would be our best bet, at least that is how I feel.

Thanks, Wolf

XCUR: NOTHING out there, Boss. Except this typical "its price is soaring, because its price is soaring" nonsense!! And the following is the SAME website that months ago said that XCUR could some day EXPLODE.
https://investorplace.com/2023/12/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-friday-dec-8th/

PS: I just got out of BED, Homeboy!!! (West Coast sucks for this stuff!!!)

XCUR .64 WHATS THE NEWS??
https://finviz.com/quote.ashx?t=XCUR&ty=c&ta=1&p=d
https://dilutiontracker.com/app/search/XCUR

XCUR: "There's something happening here; what it is ain't exactly clear."

XCUR: Some hints from old news below. (Perhaps a PR tomorrow about a Central Nervous System fix???)
https://investorplace.com/2023/04/3-nano-cap-penny-stocks-to-buy-for-explosive-gains-in-2023/

I see that too and tend to believe that Exicure finally has a private entities that will reverse merge with us. No doubt we were prime time, clean and a value just waiting on a player. we will here something as to an 8-K in the next hour or tomorrow sometime.I doubt that was insiders pumping this up but who knows for sure. I company that originally bought us after the reverse split lost their a$$ big time so I don't see another player like that to lose money again. https://www.nasdaq.com/market-activity/stocks/xcur/after-hours

EXPLODING! On what? I have no clue

XCUR: You all MISSED it!!! (Except me???)

Yeap...right on time but a 8-K instead of the late 10-Q.

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001698530/000169853023000123/xcur-20231201.htm

XCUR should be coughing up the late 10-Q tonight or Monday morning.

Holy Moly grab your socks...payback for that nasty reverse split XCUR. Mess with us shareholders... back at you!

I see XCUR went sub .50 cent recently may watch this a bit closer.

I appears when you reverse split us shareholders payback a "beach" 😂

It looks like they are trying to hold this from dropping any further but don't believe they will be successful and .50 may come into play.

That is what they get for screwing with us shareholders.

I'm still looking at the possibilities of 50 cent entry again coupled with delisting threat and RM pressures. The timing will be critical!

My thoughts on the changes of this company along with no real interest in developing existing/past XCUR technology with NWU is that they may form a distribution point. South Korean involvement is a sincere thought?

See what I mean about them trying to keep the share price at a $buck to maintain on the Nasdaq. I just don't trust these new guys running XCUR so I would think a fluffy PR will be due soon but maybe not. I can't help but think the new company had no clue about the development contract with North Western University. Not sure but believe we will see this drop much further for those who would like to buy in again. I may but need to do the math since I stayed through that nasty RS we had. We still need to see a better plan and stated in English before I lay out more money for shares plus the talks referencing XCUR obligations with NWU. I sure hated to see our technologies hit the bricks along with all the many Institution Investors and investments.

Rabbit out of the hat harder than the rug pull

It is hard to believe old management collapsed the company but they did however these new guys that decided to buy the company are from the Far East and that is fine but these guys had no idea the potential of all our workings or did they? At any rate these guys had no clue on what XCUR must do under existing contract with NW University. Seems like we have a bunch of rookies running this company. Now it is only my opinion that they (management) are trying real hard to keep the stock at least at the $1 mark for NASDAQ requirements but I believe that will fail in due time unless the company can pull a real rabbit out of their hat now I said a real rabbit not smoke and mirrors. Lastly yes I am invested here but like many decided to hold through the last RS.

OK, now the weblink below is to a filing late 8-9-23 but I will add that we knew about the non compliance problem with a clear threat pertaining to the Nasdaq listing but now Exicure is in breach of contract involving Northwestern University. This clearly means that the projected share price of .50 may drop much lower. The corporation that bought the Exicure seemingly was clueless of the development responsibilities involving past dealings with Northwestern University. Between the business structure and business plan the last thing Exicure needed was to be in breach of contract.

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001698530/000169853023000084/xcur-20230809.htm

Come to me sweetheart drop another 40 cent, I will wait!

It appears these jokers are going to sell all our remaining technology so they can continual their journey on being nothing more than a shell company waiting for one of their friends to reverse merge with us. I doubt very much if it will be a merge but rather a reverse merger. It is hard to believe that Exicure as we knew it 3 years ago could fall into this environment, just unreal plus all our patents technology and contacts mean nothing to new management. So let us watch these guys pay the leasing on that 30,000 square foot building by selling all our technology to whoever. It appears that the private company we invested that $1,000,000.00 in might be the private entity that "might" RM with us. Other thoughts are a distribution point needed in the North Eastern region of the USA. At any rate watch and see but feel strongly that we will see .50 share price in the coming months.

Come to me sweetheart .50 share price then we can tall!

Oh no, now I gotta learn how to read and speak Korean.....or whatever? Wasn't I punished enough by previous management?

Damn....you can now count on this dropping down to around your ankles big time!...maybe as low as your toe nails?